SNR Ventures
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Evidence identifies SNR Ventures as an investor in Convoke, an AI-first biotech platform for drug discovery and development, closely adjacent to OpenDrugs’ AI-enabled research workspace.